Literature DB >> 3799236

Peripheral arterial disease--natural outcome.

R Lassila, M Lepäntalo, O Lindfors.   

Abstract

Three hundred and twelve patients with peripheral arterial disease were followed up for 8 3/4 years or more (maximum 11 3/4 years) to assess the natural history of the disease and factors determining its outcome. Of the 312 patients, 188 (69%) died during the follow-up, 68% of the deaths having cardiovascular causes. The 10-year relative cumulative survival rate was 0.61 for males and 0.48 for females. The role of smoking as a risk factor could not be analysed without bias. In addition to known risk factors diabetes mellitus, cerebrovascular disease and coronary heart disease, the degree of peripheral arterial disease itself also proved to be a risk factor among men. The expected life lost for men with intermittent claudication was 20%, but 44.3% for men with advanced lower limb ischaemia (p less than 0.01). This difference could not be explained by the well-known association of advanced ischaemia and diabetes mellitus. The present results therefore suggest that the state of advanced ischaemia indicates larger involvement of the whole of the arterial tree and predicts fatal cardiovascular events among these patients.

Entities:  

Mesh:

Year:  1986        PMID: 3799236     DOI: 10.1111/j.0954-6820.1986.tb02768.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  4 in total

Review 1.  The prognosis of non-critical limb ischaemia: a systematic review of population-based evidence.

Authors:  J D Hooi; H E Stoffers; J A Knottnerus; J W van Ree
Journal:  Br J Gen Pract       Date:  1999-01       Impact factor: 5.386

2.  The effect of acetylsalicylic acid on the outcome after lower limb arterial surgery with special reference to cigarette smoking.

Authors:  R Lassila; M Lepäntalo; O Lindfors
Journal:  World J Surg       Date:  1991 May-Jun       Impact factor: 3.352

Review 3.  Beta blockers for peripheral arterial disease.

Authors:  Sharath Chandra Vikram Paravastu; Derick A Mendonca; Anthony Da Silva
Journal:  Cochrane Database Syst Rev       Date:  2013-09-11

4.  N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective µ Opioid Receptor Ligands into Dual µ/δ Opioid Receptor Agonists.

Authors:  Maria Dumitrascuta; Marcel Bermudez; Tanila Ben Haddou; Elena Guerrieri; Lea Schläfer; Andreas Ritsch; Sandor Hosztafi; Aquilino Lantero; Christoph Kreutz; Dominique Massotte; Helmut Schmidhammer; Gerhard Wolber; Mariana Spetea
Journal:  Sci Rep       Date:  2020-03-27       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.